drugset / Trial / NCT00329459

Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea

NCT00329459 ↗

Phase 3 Completed 320 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This study was designed to determine efficacy of TREXIMA compared to placebo for the treatment of a menstrual migraine.

Timeline

Start
2006-05
Primary completion
2006-11
Completion
2006-11

Outcome

Met primary endpoint

paper Two-hour pain-free rates were Study 1, 42% compared with 23%, and Study 2, 52% compared with 22%, P<.001. PMID 19546766 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Naproxen Small molecule 500 mg —
Subject Sumatriptan Unknown 85 mg —

Indications